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Abstract 
Neural tube defects (NTDs) are among the most common and severe congenital malformations and 
result from incomplete closure of the neural tube during early development. Maternal exposure to 
polycyclic aromatic hydrocarbons (PAHs) has been suggested to be a risk factor for NTDs and 
previous studies imply that the mechanism underlying the association between PAH exposure and 
NTDs may involve oxidative stress and apoptosis. The objectives of this study were to investigate 
whether there is a direct effect of maternal benzo[α] pyrene (BaP) exposure on the closure of the neural 
tube in mice, and to examine the underlying mechanisms by combining animal experiments and human 
subject studies. We found that intraperitoneal injection of BaP from embryonic day 7 at a dose of 250 
mg kg-1 induced NTDs (13.3% frequency) in ICR mice. BaP exposure significantly increased 
expression of genes associated with oxidative stress, Cyp1a1, Sod1 and Sod2, while repressing Gpx1. 
Elevated apoptosis and higher protein expression of cleaved caspase-3 in the neuroepithelium of treated 
embryos were observed. Pre-treatment with vitamin E, added to food, significantly protected against 
BaP-induced NTDs (1.4% frequency) (P < 0.05). Vitamin E also partly normalized oxidative stress 
related gene expression and excess apoptosis in BaP-treated embryos. Examination of human neural 
tissues revealed that increased levels of protein carbonyl and apoptosis were related with maternal 
exposure to PAHs and the risk of NTDs. Collectively, these results suggest that BaP exposure could 
induce NTDs and that this may involve increased oxidative stress and apoptosis, while vitamin E may 
have a protective effect. 
 
 




NTDs, neural tube defects; PAHs, polycyclic aromatic hydrocarbons; BaP, benzo[α] pyrene; ROS, 
reactive oxygen species; CYP, cytochrome P450; AhR, aryl hydrocarbon receptor; Sod, superoxide 
dismutase; Gpx, glutathione peroxidase; Cat, catalase; 8-OHdG, 8-hydroxy-2’-deoxyguanosine; PC, 
protein carbonyl; 8-iso-PGF2α, 8-iso-prostaglandin F2α; TAC, total antioxidant capacity; MDA, 
malondialdehyde; h_PAHs, high molecular weight PAHs 
Keywords  
Neural tube defects; Polycyclic aromatic hydrocarbons; Benzo[a]pyrene; Oxidative stress; Apoptosis; 
Vitamin E  
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Introduction 
Neural tube defects (NTDs) are a group of common and devastating congenital malformations that 
arise early in pregnancy due to disturbance of normal neural tube closure. NTDs occur in about one in 
every 1,000 established pregnancies worldwide [1], and it is estimated that over 323,000 births were 
affected with NTDs globally in 2001 [2]. The aetiology of NTD is thought to be heterogeneous, 
including genetic and environmental factors and their interactions [1, 3]. Factors that have been found to 
be associated with the risk of NTDs include insufficient folate [4] or multivitamin [5] intake, 
pre-gestational and gestational diabetes [6], pesticides [7] and anti-epileptic drugs [8]. However, the 
proportion of NTD cases that can be attributed to known risk factors is lower than one-third [9]. 
Polycyclic aromatic hydrocarbons (PAHs), a class of semi-volatile organic compounds ubiquitously 
present in the environment, are produced from the incomplete combustion of organic matter. PAHs 
represent a potential health threat worldwide, and have been associated with a variety of toxic effects, 
including developmental and immunological disorders, mutagenesis and carcinogenesis [10-12]. Previous 
studies have shown that PAHs can interfere with key processes of neuronal development, including 
migration, differentiation, synaptogenesis, myelination and apoptosis [13]. It is suggested that maternal 
occupational exposure to PAHs is associated with an increased risk of NTDs in offspring [7, 14, 15]. 
Human epidemiological studies have found an association between higher concentrations of PAHs in 
the venous blood of pregnant women and placental tissue with an elevated risk for NTDs, with high 
molecular weight PAHs (h_PAHs) conferring a higher risk [7, 16]. In addition, we found that higher 
levels of PAH-DNA adducts in foetal tissues were associated with increased risks of NTDs [17]. Thus, it 
was hypothesised that exposure to PAHs may be a causal event in the development of NTDs. However, 
it is not known whether PAHs directly affect mammalian neural tube formation or the mechanism by 
which they do so. 
Following absorption, PAHs undergo intracellular biotransformation to reactive intermediates by 
cytochrome P450 (CYP) enzymes, leading to production of reactive oxygen species (ROS) [18]. This 
suggests a possible mechanism by which PAHs could affect neural tube closure as oxidative stress, 
defined as a disturbance in the balance between the production of ROS and antioxidants [19], has been 
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suggested to contribute to development of some congenital malformations [20]. For example, studies to 
delineate the mechanism underlying maternal diabetic embryopathy have demonstrated that oxidative 
stress is a major contributor in NTD formation [21-23]. Excess apoptosis may be one of the mechanisms 
by which oxidative stress induces malformations. Apoptosis occurs at various developmental stages as 
a homeostatic mechanism to maintain cell populations in tissues [24]. During the formation of the neural 
tube, apoptosis appears to be dispensable; however excessive apoptosis could potentially result in 
NTDs by causing insufficient cells to be present in the fusing neural folds or by disrupting the physical 
continuity of the dorsal midline [1, 25]. Excess apoptosis is observed in the neuroepithelium of rodent 
embryos exposed to high levels of glucose in maternal serum, and deletion of pro-apoptosis kinase 
genes reduces the incidence of NTDs in these embryos [26, 27]. 
Interestingly, our previous studies found higher levels of oxidative damage markers in the serum of 
pregnant women who delivered NTD-affected foetuses than women who delivered healthy newborns 
[28]. Furthermore, we observed more apoptotic cells in neural tissues of NTD cases than normal foetuses 
[25]. It is well documented that PAHs could induce oxidative stress and human observational studies 
suggest an association between PAH exposure and oxidative damage with increased risks of NTDs. 
However, a direct effect of PAH exposure on neural tube closure has not yet been reported. Therefore, 
the aim of the present study was to examine the effect of benzo[a]pyrene (BaP), one of the most toxic 
PAHs, on neural tube closure in mice. Moreover, we asked whether BaP exposure affected oxidative 
stress status and apoptosis in the embryos and investigated the potential protective effects of vitamin E 
supplementation. In parallel, levels of redox status, makers of macromolecular oxidative damage and 
apoptosis were analysed in neural tissues of human foetuses with NTDs. 
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Material and methods 
1.1. Experimental animals 
ICR mice of 8-9 weeks old weighing 28 ± 2 g were used in the experiment. Female mice were 
mated with males overnight and vaginal plugs were examined the following morning. Noon on the day 
of finding a vaginal plug was considered 0.5 days of embryonic development (E0.5). Pregnant mice 
were randomly divided into 10 groups. In BaP-treatment groups, mice were given BaP 
intraperitoneally, dissolved in corn oil, from E6.5 or E7 for four days at doses ranging from 250 to 350 
mg kg-1. Mice in the vitamin E co-exposure group were fed with chow supplemented with the 
water-soluble (±)-α-tocopherol succinate form of vitamin E (Sigma) beginning from E0.5 (0.125%, 
w/w). All mice were maintained on a 12-h light/dark cycle and were allowed free access to food and 
water. On E10.5, pregnant mice were sacrificed by cervical dislocation and the foetuses were removed 
by caesarean section. The numbers of implantation sites, living foetuses, and reabsorbed or dead 
foetuses were recorded. All the live foetuses were carefully inspected for visible external 
malformations under a dissecting microscope. NTD-affected embryos were classified as showing 
distinct evidence of failed closure of the neural tube. Embryos for histological analysis were fixed in 
4% PFA overnight, then were dehydrated in graded ethanol, embedded in paraffin, and cut into 8-μm 
sections. After deparaffinization and rehydration, all specimens then underwent hematoxylin-eosin 
staining using a standard procedure. All neural tube sections were photographed and examined. Other 
embryos were frozen in -80 °C for further analysis. The study protocol was approved by the 
Institutional Animal Care and Use Committee of Peking University (certificate no. LA2013-36). 
1.2. Human subjects and sample collection 
The population study design has been described in our previous reports [7]. Briefly, subjects were 
recruited from an ongoing population-based birth defects surveillance system in Shanxi province of 
northern China. Cases were foetuses/newborns affected by an NTD; controls were term healthy 
newborns. Information on sociodemographic characteristics was collected through in-person interviews 
with the mothers and by viewing medical records. Samples of maternal venous blood were collected at 
delivery or termination of NTD-affected pregnancies, and were stored at -80 °C. Spinal cord and brain 
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tissues were collected from terminated foetuses following diagnose of spina bifida or cranial NTDs, 
and from induced foetuses with no congenital malformations. All samples were collected by 
experienced pathologists and frozen immediately for oxidative stress analysis or fixed in 4% PFA for 
sectioning. The study protocol was approved by the Institutional Review Board of Peking University, 
and written informed consent was obtained from all women. 
1.3. Real-time PCR 
RNA was isolated from E10.5 embryos using Trizol (Invitrogen); genomic DNA was removed by 
DNase I digestion (DNA-free, Ambion) and then reverse-transcribed using random hexamers 
(Superscript VILO cDNA synthesis kit). The abundance of mRNA of aryl hydrocarbon receptor (AhR), 
Cyp1a1, Cyp1a2, superoxide dismutase (Sod1, Sod2), glutathione peroxidase 1 (Gpx1) and catalase 
(Cat) were analysed using real-time PCR (iTaqTM Universal SYBR Green Supermix, BioRad) on a 
7500 Fast Real Time PCR system (Applied Biosystems), with each sample analysed in triplicate. 
Primers are listed in Suppl. Table1. Relative quantification of each gene expression level was 
normalized according to the Gapdh gene expression. 
1.4. Western blot 
Embryos at E10.5 were homogenised in RIPA buffer and Bradford assay was used for protein 
quantitation. Western blot was performed by conventional methods, with 50 μg of protein run per 
sample on NuPAGE 4 - 12% Bis-Tris gel (Life technologies) and transfer to PVDF membrane (XCell 
II Blot Module, Invitrogen). Primary antibodies were rabbit anti-cleaved caspase-3 (1:400, Cell 
Signaling Technology) and mouse anti-GAPDH (1:50,000, EMD Millipore). After incubation with 
secondary antibody (1:10,000, DAKO), blots were developed using ECL Prime (GE Healthcare Life 
Sciences) or ECL Western Blotting Substrate (Promega). Densitometry was performed using ImageJ. 
Results were normalized to the GAPDH loading control. Independent experiments were carried out 
three to four times for each sample. 
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1.5. TUNEL assay 
Whole mount TUNEL was performed on E9.5 embryos using the Apoptag Peroxidase in situ 
Apoptosis Detection kit (Millipore) according to the manufacturer’s instruction. Briefly, E9.5 embryos 
were rehydrated and digested with 10 µg ml-1 proteinase K for 4 min, followed by 2 mg ml-1 glycine, 
and then re-fixed in 4% PFA. After fixation, embryos were washed in PBT and incubated in 
equilibration buffer. Embryos were then incubated with terminal deoxynucleotidyl transferase 
overnight at 37 °C. Detection was performed using an alkaline phosphatase conjugated 
anti-digoxigenin antibody (Roche) and NBT/BCIP (Roche) as a substrate. After colour development, 
embryos were photographed with a DFC490 camera (Leica), and then embedded in gelatin/albumin 
mixture. Sections of 40-μm thickness were made. 
Paraffin slides of neural tissues collected from human foetuses were used for apoptotic cell injury 
assay with the one step TUNEL kit according to the manufacturer’s instruction (Beyotime Institute of 
Biotechnology). Briefly, slides were dewaxed with xylene and incubated with proteinase K, followed 
by TUNEL reaction agents for 1 hr. at 37 °C. Under a microscope (at 400-fold magnification), the cells 
with green fluorescence were defined as apoptotic cells. Four fields were randomly selected from each 
section and all the cells were successively counted for each field by an individual who was unaware of 
case-control status of the slides. The ratio of TUNEL-positive cell number to the total cell number was 
determined. 
1.6. Oxidative stress evaluation 
The methods used for analysing maternal oxidative damage markers in serum have been described 
in detail elsewhere [28]. Briefly, 8-hydroxy-2’-deoxyguanosine (8-OHdG) was used as an indicator of 
oxidative DNA damage and measured with the highly sensitive 8-OHdG check enzyme-linked 
immunosorbent assay (ELISA) kit (IMKOGHS, Jaica, Japan). Protein oxidation and lipid oxidation 
were determined by the levels of protein carbonyl (PC) and 8-iso-prostaglandin F2α (8-iso-PGF2α), 
respectively, with ELISA kits both from Cell Biolabs (San Diego, CA, USA). All samples were loaded 
in duplicate. The concentration of 8-OHdG was expressed as ng/ml, PC as nmol/mg protein, and 
8-iso-PGF2α as pg/ml. Antioxidant indicators and oxidative damage markers in foetal neural tissues 
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were determined according to the kit specifications (Nanjing Jiancheng Bioengineering Institute, 
Nanjing, China). Activity levels of SOD and GPx, total antioxidant capacity (TAC) were used as 
antioxidant indicators, and content of malondialdehyde (MDA) and PC were used as lipid and protein 
oxidation respectively.  
1.7. PAHs analysis 
The detailed procedures for PAHs analysis have been described in our previous studies [29]. Briefly, 
an agilent 7890A-5975C gas chromatograph and mass spectrometer equipped with a HP-5MS capillary 
column (30 m × 0.25 mm × 0.25 μm) was used to determine the concentration of a total of 
twenty-seven parent PAHs. Two procedure blanks and a reagent blank were included for each batch. 
PAH concentration was expressed on a lipid weight basis and reported as ng/g lipid. H_PAHs are the 
sum of high molecular weight PAHs with four or five benzene rings including pyrene, 
benz[a]anthracene, chrysene, benzo[b]fluoranthene, benzo[k]fluoranthene and benzo[a]pyrene. 
1.8. Statistical analyses 
The rates of resorption, growth retardation and malformation were calculated as a percentage of the 
total number of implantations and analysed by Pearson’s χ2 test. The abundance of mRNA and protein 
were expressed as mean ± SE (SD) and were analysed by one-way analysis of variance (ANOVA) 
followed by LSD (equal variances assumed) or Dunnett's T3 (equal variances not assumed). In human 
study, differences in proportions of population characteristics between groups were examined with 
Pearson’s χ2 test. Mann-Whitney test was used for comparisons of oxidative damage markers in 
maternal serum and foetal neural tissues by levels of h_PAHs in maternal serum, with the median of 
the controls used as the cut-off value. The levels of apoptosis and oxidative damage markers in neural 
tissue were expressed as median ± range, and compared between NTD cases and controls using 
Mann-Whitney test. A two-tail P value of < 0.05 was considered statistically significant. Statistical 
analyses were conducted using SPSS 23.0. 
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Results 
Effects of BaP on neural tube closure in foetal mice 
In order to test whether BaP could induce NTDs in a murine model, pregnant mice were 
intraperitoneally injected with various doses of BaP beginning from E6.5 or E7. On E10.5 when the 
neural tube would have closed in normal conditions, embryos were isolated and observed under a 
dissecting microscope. With increasing BaP dose, both the rates of absorbed or dead embryos and the 
rate of growth retardation increased, with the exception of the group treated with a dose of 200 mg kg-1 
BaP (Table 1). In the four groups treated from E6.5, NTD rates increased with BaP dose (P for trend < 
0.05). The group treated with 250 mg kg–1 BaP from E7 had the highest rate of NTDs (13.3%), which 
was approximately 5-fold higher than that of the control group (P < 0.01), and showed a relatively high 
proportion of live embryos (82.8%). Open regions of neural folds were not confined to a specific of the 
cranial region. The subtypes of NTDs were significantly different in E6.5 and E7 BaP treated groups (P 
< 0.05) (Fig. 1G), with a greater proportion of mid-hindbrain defects among the embryos treated at 
E6.5, while most of the NTDs induced by BaP from E7 appeared to result from closure failure in the 
forebrain (Fig. 1B-D). In addition, BaP treatment significantly affected embryo growth as shown by 
significantly shorter head lengths and crown-rump lengths in groups treated with BaP than the control 
group (P < 0.05) (Suppl. Fig. 1). Other observed malformations included microcephaly, cardiac 
abnormalities, and curved or short tail. Typical transverse section images of completely closed neural 
tube of a control embryo and unclosed neural tube of a BaP exposed embryo are shown in Fig. 1E and 
F, respectively. 
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Table 1. Embryotoxicity of BaP and the effect of vitamin E in ICR mice 
Day 










 n n n (%) n (%) n (%) n (%) n (%) n (%) 
Blank control 18 226 1 (0.4) 8 (3.5) 7 (3.1) 3 (1.3) 6 (2.7) 2 (0.9) 
E6.5 Corn oil 11 136 1 (0.7) 2 (1.5) 2 (1.5) 2 (1.5) 2 (1.5) 2 (1.5) 







































E7 Corn oil 12 151 0 9 (6.0) 1 (0.7) 3 (2.0) 3 (2.0) 3 (2.0) 
E7 250+VE 11 144 1 (0.7) 13 (9.0) 18 (12.5) 1 (0.7) 2 (1.4) 68 (47.2) 


























E7 350 10 136 18 (13.2)
b









aP < 0.05, compared with E6.5 corn oil; bP < 0.05, compared with E7 corn oil; cP < 0.05, compared 
with E7 250+VE. VE, vitamin E. 
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Fig. 1. NTDs in E10.5 mouse embryos exposed to BaP (A) Control E10.5 embryo; (B-D) E10.5 
embryos exposed to BaP with NTDs; (B) Embryo with closure failure in the brain (arrow); (C) Embryo 
with unfused neural folds resulting in anencephaly (arrow); (D) Embryo with exencephaly near the 
midbrain (arrow); (E and F) H&E staining of the control and NTD embryos, closed neural tube (E) and 
open neural plate (F) are indicated by arrows, sectioned along the plane indicated by the white line in A 
and B, respectively; (G) NTD subtype distribution of E10.5 mouse embryos exposed to BaP. Embryos 
treated with BaP from E6.5 were found mainly with unfused neural folds at mid and hindbrain , while 
embryos in E7 exhibited anencephaly with neural folds unfused at forebrain. fb, forebrain; mb, 
midbrain; hb, hindbrain. 
Effect of maternal vitamin E supplementation on NTDs induced by BaP 
We hypothesised that BaP could act to induce oxidative stress so we tested whether treatment with 
the antioxidant vitamin E alleviates the effect of BaP on neural tube closure. Pregnant mice treated with 
BaP from E7 with 250 mg kg-1 were fed with vitamin E supplemented chow beginning from E0.5. 
Although vitamin E had no significant effects on foetal resorption and growth, it significantly 
attenuated BaP induced foetal lethality and NTDs (Table 1). Compared with the BaP treated group (E7 
250 mg kg–1), NTD rate of the vitamin E supplemented group (1.4%) was decreased to a level close to 
that of the control group. 
13 | P a g e  
 
Effect of BaP exposure and vitamin E supplementation on oxidative stress related gene 
expression 
We further hypothesised that vitamin E may prevent BaP-induced NTDs by acting as an 
antioxidant. To test this hypothesis, we analysed the mRNA levels of several enzymes, including 
Cyp1a, Sod1, Sod2, Cat and Gpx1, whose expression is associated with oxidative stress. We also 
analysed AhR, encoding the Aryl Hydrocarbon Receptor which is thought to mediate transcriptional 
signals in response to environmental toxins such as PAHs. The expression of AhR in the BaP-treated 
group was lower than that in controls (Fig. 2) and a linear correlation between the levels of AhR mRNA 
and BaP dose was observed. Notably, vitamin E treatment normalised AhR expression level. 
Expression of the oxidative stress responsive genes Cyp1a1 and Cyp1a2 was increased in BaP-treated 
embryos, with the effect on Cyp1a1 being more pronounced, as shown by almost 20-fold higher 
expression in BaP exposed embryos than in the control group (P < 0.05). Unexpectedly, in the vitamin 
E co-exposure group, Cyp1a1 mRNA showed a significant increase compared to the BaP-treated 
group, while Cyp1a2 was not responsive to vitamin E. 
Analysis of expression of mRNA encoding antioxidant enzymes, Sod1 and Sod2, showed that the 
expression of both genes increased in the BaP-treated group by nearly 2-fold. When vitamin E was 
co-administered, the induced expression of Sod1 and Sod2 was normalised. In contrast to Sod genes, 
BaP-treated embryos showed a significantly decreased level of Gpx1, and co-administration with 
vitamin E failed to restore the level to that of the control group. Cat gene expression was not 
responsive to BaP or vitamin E. 
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Fig. 2. Relative expression of mRNA of E10.5 embryos exposed to BaP and co-exposed to vitamin 
E by real-time PCR. Data for AhR, Cyp1a1, Cyp1a2, Sod1, Sod2, Cat and Gpx1 were normalized by 
Gapdh for each sample (mean ± SE; n = 4-8). *P < 0.05 or **P < 0.01 or ***P < 0.001 vs control; #P < 
0.05 or ##P < 0.01 or ###P < 0.001 vs vitamin E supplemented. VE, vitamin E. 
The role of apoptosis in BaP induced NTDs 
The smaller size and head length of BaP-treated embryos (Suppl. Fig. 1) suggested a possible effect 
of BaP on cell proliferation or death. Given the association of oxidative stress with cell death, we 
examined whether apoptosis was altered in BaP-exposed embryos by whole mount TUNEL assay (Fig. 
3A). Apoptotic cells were detectable along the dorsal midline of the whole brain of both control 
embryos and BaP-treated embryos. However, transverse sectioning showed more apoptotic cells at 
defective sites of BaP-treated embryos, and apoptosis in the hindbrain region was most obvious, while 
neuroepithelial apoptosis was relatively low in control embryos. 
Cleaved caspase-3 is considered as the end point of caspase activation and provides a measure of 
apoptosis. We analysed cleaved caspase-3 levels by western blot of samples derived from E10.5 
embryos. The protein abundance of cleaved caspase-3 in BaP-treated embryos was much higher than 
that in the control group, and co-exposure to vitamin E attenuated the effect of BaP (Fig. 3B and C). 
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Fig. 3. The effects of BaP and vitamin E on apoptosis levels in E9.5 and E10.5 embryos. (A) Whole 
mount in situ TUNEL staining was performed on E9.5 embryos to detect BaP-induced apoptosis (n = 6). 
The dashed lines on the whole mount panels indicate the orientation of respective sections. (B) 
Representative western blot images of cleaved caspase-3 and GAPDH expressions. (C) Expression of 
cleaved caspase-3 in E10.5 embryos was normalized against GAPDH and represented as mean ± SD to 
that of control (n = 6). ***P < 0.001 vs control; ###P < 0.001 vs vitamin E supplemented.VE, vitamin E. 
PAH exposure, oxidative stress, apoptosis and NTDs in human subjects 
Having found that BaP exposure can directly cause NTDs in mice and that this may involve 
induction of oxidative stress and excess apoptosis, we asked whether there was evidence for the 
presence of these features in human NTDs, which would suggest a potential contribution of PAH 
exposure to NTD aetiology. The characteristics of human NTD cases and controls are summarized in 
Suppl. Table 2. We determined the concentration of PAHs and oxidative damage markers in maternal 
serum of these subjects. A subgroup with available foetal neural tissues was further used to evaluate the 
possible association of oxidative status and apoptosis levels in neural tissues with the risk of NTDs. 
Detailed information on the demographic characteristics of this sub-population is shown in Suppl. 
Table 3. No significant differences were observed between cases and controls with regard to maternal 
characteristics, including maternal age and foetal gestational age. 
A significantly higher level of PC was observed in serum of women whose serum h_PAHs 
concentration was above the median concentration of the controls when compared to those below the 
median (Fig. 4), while the concentration of 8-OHdG and 8-iso-PGF2α levels in maternal serum did not 
differ significantly with PAH levels. We also asked whether the MDA, TAC, SOD or GPx activity in 
foetal neural tissue correlated with maternal serum h_PAH concentration. However, we did not observe 
significant between the ‘high’ and ‘low’ maternal h_PAH groups. 
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Fig. 4. Oxidative stress and antioxidative stress markers by levels of h_PAHs in maternal serum. 
(A) Levels of maternal markers of macromolecular oxidative damage in maternal serum by h_PAHs in 
maternal serum (n = 230). The maternal PC level of the h-PAHs above the median group was 
significantly higher than that of the below median group (P = 0.019). (B) Markers of redox status and 
markers of macromolecular oxidative damage in foetal neural tissues by h_PAHs in maternal serum (n 
= 23). Serum h_PAHs concentration, dichotomized with the median of PAH in control group as the 
cut-off. *P < 0.05, compared with control group. 
Next, we compared levels of oxidative stress markers in neural tissue from foetuses with NTDs 
and controls (no NTDs). MDA levels did not differ but the median concentration of PC in neural 
tissues was significantly higher in the case group (2.25 nmol/mg protein) than that in the control group 
(1.41 nmol/mg protein) (P = 0.037) (Fig. 5), suggesting the presence of oxidative stress in NTD neural 
tissues. The activities of SOD and GPx tended to be higher in case group, and the level of TAC tended 
to be lower in the case group; however, the differences were not statistically significant. 
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Fig. 5. Association between oxidative status in foetal neural tissue and NTDs. Comparison of redox 
status (TAC, SOD and GPx) and makers of macromolecular oxidative damage (PC and MDA) in foetal 
neural tissues between NTDs (n = 27) and controls (n = 10). *P < 0.05, compared with control group. 
Having detected a higher abundance of PC in neural tissues of NTD foetuses, we tested whether 
apoptosis may also occur at a higher level by performing TUNEL staining on tissue sections. As shown 
in Fig. 6A-D, more TUNEL-positive cells were observed in case neural tissues than that in control 
neural tissues. The median percentage of TUNEL-positive cells in foetal neural tissue was 30.92% in 
cases, significantly higher than that of controls, which was 7.06% (Fig. 6F). Subtypes of NTDs, namely 
anencephaly and spina bifida, also showed higher percentages of TUNEL-positive cells than controls 
(46.84% for anencephaly; 23.79% for spina bifida). The percentage of TUNEL-positive cells in foetal 
neural tissues was positively correlated to the concentration of PAHs in maternal serum (Fig. 6E). 
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Fig. 6. Apoptosis in foetal neural tissue detected by TUNEL. (A-D) Representative images of 
TUNEL-stained neural tissue from a NTD case (C and D) and a control (A and B). TUNEL-positive 
nuclei were in green fluorescent colour and DAPI staining was performed to visualize the total cell 
number (blue). (E and F) Apoptosis rate was calculated as percent of TUNEL-positive cells out of total 
cells (median ± range). (E) Correlation between apoptosis level in foetal neural tissue and h_PAHs 
concentration in maternal serum (n = 39). (F) Comparison of apoptosis rate in foetal neural tissue 
between NTD-affected foetuses (n =39) and controls (n = 18). Data were presented as box plots, where 
the boxed represent the 25h to 75th percentiles, the lines within the boxes represent the median, and the 
lines outside the boxes represent the 10th and 90th percentiles. **P < 0.01, ***P < 0.001, compared with 
control group.  
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Discussion 
PAHs are ubiquitous environmental pollutants. Our [7, 16, 17] and other [14] epidemiological studies 
have suggested that maternal exposure to PAHs is associated with an elevated risk of NTDs in the 
offspring. However, evidence from animal experiments is limited. It has been shown that BaP can 
interfere with anterior neuropore closure in mouse whole embryo culture [30, 31]. However, maternal and 
placental effects could not be evaluated in this model. In another study, 
benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide, an important metabolic derivative of BaP, was injected 
directly into mouse embryos on E10 [32]. However, neural tube closure is almost finished in mice by 
E10 [1], such that cranial closure could not be evaluated, and exposure through direct injection also 
bypasses maternal metabolism. In this context, we focused on deciphering whether PAHs could induce 
NTDs through maternal exposure during early organogenesis. We found that intraperitoneal treatment 
with BaP on E7 can result in significantly increased incidence of NTDs. This mouse model may be of 
significance in elucidating the epidemiological association between maternal PAH exposure and NTDs. 
Oxidative stress has been implicated in the aetiology of congenital anomalies caused by maternal 
diabetes, valproic acid, alcohol intake and several environmental toxins [8, 33-36]. After entering the 
body, BaP binds with AhR, activates the expression of CYP genes, and is metabolized by CYP 
enzymes to epoxides, which are further hydrated to various dihydrodiols by epoxide hydrolase, 
resulting in oxidative stress [18]. AhR is a member of the transcription factor, which is well-known to 
mediate the toxicological response of environmental contaminants such as PAHs. Recently, AhR is 
proposed as a potent suppressor of oxidative stress [37]. The decreased expression of AhR observed in 
present study may imply the repressed antioxidant capacity of embryos after BaP treatment. Expression 
of Cyp1a1 and Cyp1a2 were selected as indicators for activation of oxidative stress [38, 39]. A 
dramatically increased level of Cyp1a1 mRNA was observed in the BaP-treatment group, which 
indicates possible activation of oxidative stress induced by BaP. However, the expression of Cyp1a2 
was not altered after BaP treatment. The differential induction of Cyp1a1 and Cyp1a2 was also found 
in other studies on BaP [40]. A possible explanation for this is that Cyp1a2 is constitutively expressed at 
higher levels mainly in liver, while Cyp1a1 is primarily extrahepatically expressed, with brains as one 
of the main organs [41-43]. Thus, our findings are supported by previous studies and suggest that Cyp1a1 
is of more significance in local metabolism of BaP in neural tissues during early development in mice. 
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Stimulation of the expression of genes encoding oxidative stress-scavenging enzymes has been 
proposed to act as a mechanism of defence against damage induced by oxidative stress during diabetic 
pregnancy [44, 45]. SODs represent a family of cellular enzymes involved in converting superoxide into 
peroxide, which can then be converted into water by CAT and GPx. We observed in present animal 
study that the levels of Sods were elevated in the BaP-treatment group, which has also been reported in 
mice and rats treated with PCBs, Aroclor 1254 and tetrachlorobiphenyls [46-49]. However, no increase 
was seen in the expressions of Gpx1 and Cat after BaP exposure. The absence of the up-regulation of 
these two antioxidant enzymes was also found in studies done with scallops of Chlamys farreri [50], 
scallops N. nodosus [51], and roach (Rutilus rutilus) [52]. It was demonstrated in cultured mouse embryos 
that SODs can significantly reduce the incidence of NTDs induced by BaP and ethanol [30, 53]. In present 
study, the elevated Sods, however, were accompanied with an increased incidence of NTDs after BaP 
exposure. One possible explanation is that although the expression of Sods increased, the repressed Cat 
and Gpx1 expression after BaP exposure failed to cooperate with Sods to detoxify hydrogen peroxide to 
water, which might favour the accumulation of H2O2. It was proposed that it is the balance in the 
activity of the SOD to GPx plus CAT ratio (SOD/(GPX plus CAT)) that is an important determinant in 
the antioxidant defence system against pathologies [54, 55]. An elevation in the ratio of SODs activity to 
GPx1/CAT activity was found to be correlated with increased lipid damage and cellular senescence 
and/or cell death [54, 56, 57]. Our present data are consistent with these studies, supporting the idea that the 
balance in the antioxidant defence system is of more significance for oxidative stress resistance under 
stressed conditions. 
To further explore the role of oxidative stress in BaP induced NTDs, we co-administered BaP with 
vitamin E, which has been shown to protect against oxidative stress related BaP metabolism [58-60]. As 
expected, the proportion of NTD affected embryos in the vitamin E-supplemented group was 
considerably lower than that in the BaP-treated group. Pre-treatment with vitamin E attenuated the 
elevated expressions of Sod1 and Sod2 induced by BaP as well. The same regulation effect of vitamin 
E on Sods was also found in animal studies treated with deltamethrin and PCB126 [61, 62]. Unexpectedly, 
we found that co-administration with vitamin E enhanced the level of Cyp1a1 about 2-fold compared 
with the BaP-treatment group. This seemingly conflicting inductive effect of vitamin E on the 
expression of Cyp1a1 has been previously reported in oestrogen-induced mammary tumorigenesis [63]. 
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Based on the data from our study, one possible explanation is that vitamin E alleviated the inhibition of 
BaP on AhR, the activation of which could up-regulate Cyp1a expression. Furthermore, CYP genes are 
not only regulated by AhR, but also by other nuclear receptors, including Pregnane X Receptor, which 
also responds to modulation by vitamin E [64]. Another explanation may be that apart from its 
antioxidant activity, vitamin E as a lipid-soluble antioxidant, follows the metabolic pathway of dietary 
lipid in the body, which also involves the activation of CYP enzymes. It is suggested in recent studies 
that the role of Cyp1 induction is required for rapid clearance of BaP [65] and the inhibition of Cyp1 
could amplify the carcinogenic and teratogenic effects of PAHs [66, 67]. When Cyp1a was inhibited, the 
rate of PAHs metabolism decreased, extending the half-life of PAHs and allowing parent PAHs to 
persist longer as evidenced by the increased toxicity of PAHs after Cyp1a knockdown or inhibition 
[68-70]. This may explain the decreased rate of NTDs in vitamin E supplemented group accompanied 
with induction of Cyp1a, indicating the protective role of vitamin E may be related with facilitating the 
clearance of BaP.  
Levels of redox status, makers of macromolecular and oxidative damage were also analysed in 
human tissues to explore whether similar mechanisms were included in the aetiology of human NTDs. 
And we found increased levels of PC in maternal serum and foetal neural tissues in the group with 
higher PAH exposure, indicating a potential contribution of maternal PAH exposure to oxidative stress 
in both pregnant women and foetuses. In addition, the concentration of PC in NTD foetal neural tissues 
was significantly higher than that of controls. PC is one of the most widely used oxidative markers and 
the accumulation of PC has been observed in a NTD mouse model induced by maternal diabetes [71, 72], 
which is in line with our finding. However, unlike in BaP-treated mice, where expression of Sods was 
increased and Gpx1 decreased, we did not observe a significant change in SODs and GPx activity in 
human tissue with exposure to higher PAH or in NTDs. This discrepancy may be due to the short-term, 
more acute treatment in the mouse model in which development stages and the timing of exposure can 
be strictly controlled. Collection of biological samples from human foetuses is difficult and it is not 
feasible to obtain neural tissue at the stage when the neural tube is closing. Therefore, the observational 
human study is subject to the influence of many factors as well as a limited sample size for analysis of 
oxidative stress and redox markers. Future studies should expand the sample size and collect tissue 
samples as close to the window of neural tube closure as possible. 
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Growing evidence indicates that oxidative stress can stimulate apoptosis, which may lead to 
insufficient cell numbers to participate in folding and fusion of neural walls of the neural tube [73-75]. In 
Cited2 mutant embryos, NTDs are associated with excessive neuroepithelial cell death, which leads to 
insufficient cell numbers to take part in the crucial morphogenetic movements for neural tube closure 
[76]. Supportively, we observed increased levels of TUNEL-positive cells and cleaved caspase-3 in the 
neuroepithelium of the mouse brain after exposure to BaP. And we further found that vitamin E could 
alleviate the increased expression of cleaved caspase-3 induced by BaP, which imply a possible role of 
oxidative stress in stimulation of apoptosis. This is in consistent with Numakawa’s study which 
reported pre-treatment with vitamin E could prevented cell death in cultured cortical neurons 
stimulated with peroxide [77]. To our knowledge, direct studies of apoptosis in human NTDs foetus are 
very limited. We showed here that more TUNEL-positive cells were observed in the central nervous 
tissues of foetuses with NTDs than those of controls. Furthermore, we provided additional evidence of 
a positive correlation between increased apoptosis levels in foetal neural tissues and a higher 
concentration of PAHs in maternal serum. Taken together, these findings suggest a role of apoptosis in 
NTDs induced by BaP, and apoptosis may be activated through the pathway mediated by oxidative 
stress. However, one limitation is that human tissues were mostly collected at second trimester, while 
the closure of neural tube completes at the first month of pregnancy. This drawback could not be 
eliminated with routine case-control design, as the neural tissues of foetus can only be sampled at 
elective termination after a diagnose of NTDs. In addition, when analysing by gestational age in the 
case or control group separately, we did not found differences in the apoptosis level between 
gestational age younger or older than 28 weeks, suggesting that gestational age has no impact on 
apoptosis level in the present study. 
In conclusion, to our knowledge this study is the first to explore whether maternal BaP exposure 
could induce NTDs in embryos and to assess the potential role of oxidative stress and apoptosis in the 
aetiology of BaP embryotoxicity. Our results demonstrate that maternal exposure to BaP can induce 
NTDs in the embryo and suggest that oxidative stress and apoptosis may be involved in the formation 
of NTDs after BaP exposure. In humans, increased levels of makers of macromolecular oxidative 
damage and apoptosis are associated with NTDs, which may be also associated with maternal exposure 
to PAHs. We further show that vitamin E treatment significantly reduced the frequency of NTDs, 
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possibly through its anti-oxidation and anti-apoptosis effects, making antioxidants may be good 
candidates for preventing NTDs resistant to folic acid. However, in consideration of potentially 
harmful health effects of excess vitamin E, the recommendation of vitamin E supplementation during 
pregnancy must carefully balance both the risks and benefits. 
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 Intraperitoneal BaP injection induced neural tube defects (NTDs) in foetal mice. 
 Maternal BaP exposure altered oxidative stress related gene expression and induced 
apoptosis in foetal mice. 
 Vitamin E rescued BaP-induced NTDs in foetal mice may partly realized via its 
antioxidative and anti-apoptotic properties. 
 PAH concentrations were associated with protein carbonyl (PC) levels in human 
maternal serum. 
 Elevated PC and apoptosis in human foetal neural tissues were associated with 
increased NTD risk. 
